Literature DB >> 6808697

Activation of human coagulation factor VIII by activated factor X, the common product of the intrinsic and the extrinsic pathway of blood coagulation.

K Mertens, R M Bertina.   

Abstract

The intrinsic activation of human factor X has been studied in a system consisting of purified factors and in plasma. In both these systems factor Xa stimulated the activation of factor X by factor IXa plus factor VIII. This is due to the activation of factor VIII by factor Xa. When this factor Xa is formed via the extrinsic pathway, the extrinsic factor X activator functions as a stimulator of the intrinsic factor X activator.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6808697

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  7 in total

1.  Dissimilar interaction of factor VIII with endothelial cells and lipid vesicles during factor X activation.

Authors:  H J Brinkman; P Koster; K Mertens; J A van Mourik
Journal:  Biochem J       Date:  1997-05-01       Impact factor: 3.857

2.  Selective factor VIII activation by the tissue factor-factor VIIa-factor Xa complex.

Authors:  Yuichi Kamikubo; G Loredana Mendolicchio; Antonella Zampolli; Patrizia Marchese; Andrea S Rothmeier; Jennifer Nagrampa Orje; Andrew J Gale; Sriram Krishnaswamy; András Gruber; Henrik Østergaard; Lars C Petersen; Wolfram Ruf; Zaverio M Ruggeri
Journal:  Blood       Date:  2017-07-20       Impact factor: 22.113

3.  Binding of human blood-coagulation Factors IXa and X to phospholipid membranes.

Authors:  K Mertens; R Cupers; A Van Wijngaarden; R M Bertina
Journal:  Biochem J       Date:  1984-11-01       Impact factor: 3.857

4.  The contribution of Ca2+ and phospholipids to the activation of human blood-coagulation Factor X by activated Factor IX.

Authors:  K Mertens; R M Bertina
Journal:  Biochem J       Date:  1984-11-01       Impact factor: 3.857

5.  Inhibition of human coagulation factor VIII by monoclonal antibodies. Mapping of functional epitopes with the use of recombinant factor VIII fragments.

Authors:  A Leyte; K Mertens; B Distel; R F Evers; M J De Keyzer-Nellen; M M Groenen-Van Dooren; J De Bruin; H Pannekoek; J A Van Mourik; M P Verbeet
Journal:  Biochem J       Date:  1989-10-01       Impact factor: 3.857

6.  Characterization of des-(741-1668)-factor VIII, a single-chain factor VIII variant with a fusion site susceptible to proteolysis by thrombin and factor Xa.

Authors:  M J Donath; R T de Laaf; P T Biessels; P J Lenting; J W van de Loo; J A van Mourik; J Voorberg; K Mertens
Journal:  Biochem J       Date:  1995-11-15       Impact factor: 3.857

7.  Genetic Deletion of HLJ1 Does Not Affect Blood Coagulation in Mice.

Authors:  Man-Chen Hsu; Wei-Jia Luo; Bei-Chia Guo; Chia-Hui Chen; Po-An Hu; Yi-Hsuan Tsai; Kang-Yi Su; Tzong-Shyuan Lee
Journal:  Int J Mol Sci       Date:  2022-02-13       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.